Literature DB >> 77426

Clinical outcome of the first ten years of ulcerative colitis and proctitis.

J K Ritchie, J Powell-Tuck, J E Lennard-Jones.   

Abstract

269 patients with ulcerative colitis and a history of less than 6 months when first seen at St. Mark's Hospital in the decade 1966--75 have been followed for up to 11 years. The outcome has been correlated with the maximum extent of the disease observed within 3 months of presentation. 75 patients required hospital admission, 56 within a year of presentation. Extensive colitis developed in 60 patients. The cumulative probability of the disease being extensive was 21% +/- 3% at 5 years and 29% +/- 4% at 10 years. 25 patients required surgical treatment. The cumulative probability of operation was 8% +/- 2% at 5 years and 15% +/- 4% at 10 years. 19 patients are known to have died. The expected number of deaths was 19.2.

Entities:  

Mesh:

Year:  1978        PMID: 77426     DOI: 10.1016/s0140-6736(78)90312-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  28 in total

1.  Ulcerative colitis extent varies with time but endoscopic appearances may be deceptive.

Authors:  J M Rhodes
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

2.  Prognostic indicators and clinical course in proctosigmoiditis.

Authors:  L D Juby; D E Long; M F Dixon; A T Axon
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

Review 3.  The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.

Authors:  M Anthony Sofia; David T Rubin
Journal:  Dig Dis Sci       Date:  2017-04       Impact factor: 3.199

4.  Ulcerative colitis: one disease or two? (Quantitative histological differences between distal and extensive disease).

Authors:  D Jenkins; A Goodall; B B Scott
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

5.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

6.  Topiramate use does not reduce flares of inflammatory bowel disease.

Authors:  Seth D Crockett; Robin Schectman; Til Stürmer; Michael D Kappelman
Journal:  Dig Dis Sci       Date:  2014-02-07       Impact factor: 3.199

7.  Indications for and results of operation in inflammatory bowel disease.

Authors:  P F Schofield; J M Manson
Journal:  J R Soc Med       Date:  1986-10       Impact factor: 5.344

8.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

9.  Clinical course and long-term prognosis of Japanese patients with ulcerative colitis.

Authors:  N Hiwatashi; H Yamazaki; M Kimura; T Morimoto; H Watanabe; T Toyota
Journal:  Gastroenterol Jpn       Date:  1991-06

10.  Ulcerative colitis treated by excision of the distal large bowel alone.

Authors:  G Nakano; J K Ritchie; J P Thomson
Journal:  Postgrad Med J       Date:  1984-04       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.